181 related articles for article (PubMed ID: 2445912)
1. Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysis.
Kitayama I; Janson AM; Fuxe K; Agnati LF; Cintra A; Ogren SO; Härfstrand A; Eneroth P; Tsutsumi T; Jonsson G
J Neural Transm; 1987; 70(3-4):251-85. PubMed ID: 2445912
[TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxytryptamine, substance P, and thyrotropin-releasing hormone in the adult cat spinal cord segment L7: immunohistochemical and chemical studies.
Arvidsson U; Cullheim S; Ulfhake B; Bennett GW; Fone KC; Cuello AC; Verhofstad AA; Visser TJ; Hökfelt T
Synapse; 1990; 6(3):237-70. PubMed ID: 1700485
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin-releasing hormone (TRH)-like immunoreactivity in the grey monkey (Macaca fascicularis) spinal cord and medulla oblongata with special emphasis on the bulbospinal tract.
Arvidsson U; Ulfhake B; Cullheim S; Shupliakov O; Brodin E; Franck J; Bennett GW; Fone KC; Visser TJ; Hökfelt T
J Comp Neurol; 1992 Aug; 322(3):293-310. PubMed ID: 1517482
[TBL] [Abstract][Full Text] [Related]
4. The serotoninergic bulbospinal system and brainstem-spinal cord content of serotonin-, TRH-, and substance P-like immunoreactivity in the aged rat with special reference to the spinal cord motor nucleus.
Johnson H; Ulfhake B; Dagerlind A; Bennett GW; Fone KC; Hökfelt T
Synapse; 1993 Sep; 15(1):63-89. PubMed ID: 7508641
[TBL] [Abstract][Full Text] [Related]
5. A thyrotropin-releasing hormone-containing system in the rat dorsal horn separate from serotonin.
Harkness DH; Brownfield MS
Brain Res; 1986 Oct; 384(2):323-33. PubMed ID: 3096489
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin-releasing hormone-immunoreactive neurons project from the ventral medulla to the intermediolateral cell column: partial coexistence with serotonin.
Helke CJ; Sayson SC; Keeler JR; Charlton CG
Brain Res; 1986 Aug; 381(1):1-7. PubMed ID: 2428429
[TBL] [Abstract][Full Text] [Related]
7. The effects of 5-hydroxytryptamine-depleting drugs on peptides in the ventral spinal cord.
Gilbert RF; Bennett GW; Marsden CA; Emson PC
Eur J Pharmacol; 1981 Dec; 76(2-3):203-10. PubMed ID: 6174352
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin-releasing hormone in spinal cord: coexistence with serotonin and with substance P in fibers and terminals apposing identified preganglionic sympathetic neurons.
Appel NM; Wessendorf MW; Elde RP
Brain Res; 1987 Jul; 415(1):137-43. PubMed ID: 2441808
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evidence for the coexistence of substance P, thyrotropin-releasing hormone, GABA, methionine-enkephalin, and leucin-enkephalin in the serotonergic neurons of the caudal raphe nuclei: a dual labeling in the rat.
Kachidian P; Poulat P; Marlier L; Privat A
J Neurosci Res; 1991 Nov; 30(3):521-30. PubMed ID: 1724785
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative aspects on the distribution of 5-HT and its coexistence with substance P and TRH in cat ventral medullary neurons.
Arvidsson U; Cullheim S; Ulfhake B; Luppi PH; Kitahama K; Jouvet M; Hökfelt T
J Chem Neuroanat; 1994 Jul; 7(1-2):3-12. PubMed ID: 7528511
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the immunohistochemical localization of a presumptive proctolin-like peptide, thyrotropin-releasing hormone and 5-hydroxytryptamine in the rat central nervous system.
Holets VR; Hökfelt T; Ude J; Eckert M; Penzlin H; Verhofstad AA; Visser TJ
Brain Res; 1987 Apr; 408(1-2):141-53. PubMed ID: 3109686
[TBL] [Abstract][Full Text] [Related]
12. Regional distribution of substance P- and thyrotrophin-releasing hormone-like immunoreactivity and indoleamines in the rabbit spinal cord.
Fone KC; Bennett GW; Marsden CA
J Neurochem; 1987 Apr; 48(4):1027-32. PubMed ID: 2434614
[TBL] [Abstract][Full Text] [Related]
13. Influences of both thyroid and bovine growth hormones on substance P, thyrotropin-releasing hormone, serotonin and 5-hydroxyindoleacetic acid contents in the lumbar spinal cord of developing rats.
Savard P; Blanchard LM; Mérand Y; Bédard P; Dussault JH; Dupont A
Brain Res; 1984 Mar; 315(1):105-10. PubMed ID: 6202374
[TBL] [Abstract][Full Text] [Related]
14. Regional distribution of immunoreactive-thyrotrophin-releasing hormone and substance P, and indoleamines in human spinal cord.
Bennett GW; Nathan PA; Wong KK; Marsden CA
J Neurochem; 1986 Jun; 46(6):1718-24. PubMed ID: 2422323
[TBL] [Abstract][Full Text] [Related]
15. Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male rat.
Kitayama I; Cintra A; Janson AM; Fuxe K; Agnati LF; Eneroth P; Aronsson M; Härfstrand A; Steinbush HW; Visser TJ
J Neural Transm; 1989; 77(2-3):93-130. PubMed ID: 2760606
[TBL] [Abstract][Full Text] [Related]
16. Evidence for 5-hydroxytryptamine, substance P, and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus.
Holtman JR; Norman WP; Skirboll L; Dretchen KL; Cuello C; Visser TJ; Hökfelt T; Gillis RA
J Neurosci; 1984 Apr; 4(4):1064-71. PubMed ID: 6201597
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla.
Kitayama I; Janson AM; Cintra A; Fuxe K; Agnati LF; Ogren SO; Härfstrand A; Eneroth P; Gustafsson JA
J Neural Transm; 1988; 73(3):191-203. PubMed ID: 3210008
[TBL] [Abstract][Full Text] [Related]
18. Distribution of 125I-galanin binding sites, immunoreactive galanin, and its coexistence with 5-hydroxytryptamine in the cat spinal cord: biochemical, histochemical, and experimental studies at the light and electron microscopic level.
Arvidsson U; Ulfhake B; Cullheim S; Bergstrand A; Theodorson E; Hökfelt T
J Comp Neurol; 1991 Jun; 308(1):115-38. PubMed ID: 1714921
[TBL] [Abstract][Full Text] [Related]
19. Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion.
Saphier D; Welch JE; Farrar GE; Nguyen NQ; Aguado F; Thaller TR; Knight DS
Psychoneuroendocrinology; 1994; 19(8):779-97. PubMed ID: 7527566
[TBL] [Abstract][Full Text] [Related]
20. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.
Iverfeldt K; Peterson LL; Brodin E; Ogren SO; Bartfai T
Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):1-6. PubMed ID: 2426604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
